People · Operator
Named in public records as an officer, director or promoter · active 2009–2026 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ZeroCarb Inc. | — | Other | Seed | $5.2M | $495K | 2022 |
| Ancora Pharmaceuticals Inc | — | Biotechnology | Pre-Seed | $800K | $44.2M | 2009 |
John Pena at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Pena on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carmichael Roberts | 1 | 15 |
| Shaun Hawkins | 1 | 4 |
| Mohamed Aly | 1 | 2 |
| Karl White | 1 | 2 |
| Barry Buckland | 1 | 2 |
| Wesam Saber | 1 | 1 |
| Mitsi Ushio | 1 | 1 |
| Doug Jamison | 1 | 1 |
| Peter Seeberger | 1 | 1 |
| Haytham Mohamed | 1 | 1 |
| Bob Kirch | 1 | 1 |
| Omar Atia | 1 | 1 |
| Leslie Hawkins | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.